Recordati reported EUR220.03M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Almirall EUR 195.09M 100.89M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Orion EUR 168.1M 15.3M Jun/2025
Sanofi EUR 2.99B 103M Jun/2025